Gadoteridol (pentahydrate)

Gadoteridol (pentahydrate)

• UNSPSC Description: Gadoteridol pentahydrate is a gadolinium-based magnetic resonance imaging (MRI) contrast agent, used in the imaging of the central nervous system[1].
• Target Antigen: Biochemical Assay Reagents
• Type: Reference compound
• Related Pathways: Others
• Applications: Neuroscience-Neuromodulation
• Field of Research: Neurological Disease; Cancer
• Assay Protocol: https://www.medchemexpress.com/gadoteridol-pentahydrate.html
• Solubility: 10 mM in DMSO
• Smiles: CC1O[Gd+3]2([N]3(CC4)CC5=O)([N]6(CC7)CC([O-]2)=O)([N]47CC8=O)([O-]8)([O-]5)[N](CC6)(CC3)C1.O.O.O.O.O
• Molecular Weight: 647.75
• References & Citations: [1]Hullinger R, et al. The MRI contrast agent gadoteridol enhances distribution of rAAV1 in the rat hippocampus. Gene Ther. 2013 Dec;20(12):1172-7.
• Shipping Conditions: Room temperature
• Clinical Information: Launched